Home » Topics » BioWorld Science

BioWorld Science
RSS

Melarsoprol normalizes cytokine levels in human African trypanosomiasis

July 29, 1997

Statins protect against stroke and CVD

July 29, 1997

InSite Vision: Q2 1997 highlights

July 29, 1997

Ilex Oncology: Q2 1997 highlights

July 29, 1997

RPR prepares novel transfection agents

July 29, 1997

Merck KGaA discloses novel ET antagonists

July 29, 1997

Repligen identifies angiogenic growth factor inhibitors

July 29, 1997

Mylan enters distribution agreement for ranitidine

July 29, 1997

Potential alternative for long-term treatment of obesity

July 28, 1997

BioTime's Hextend enters European clinical trials; licensed to Abbott

July 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors
BioWorld Science
Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...